BeiGene Ltd.

NASDAQ: BGNE · Real-Time Price · USD
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 10:00 PM

BeiGene Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.63B 3.17B 3.87B 4.38B
Short-Term Investments
n/a 2.6M 665.25M 2.24B
Long-Term Investments
128.93M 89.64M 91.78M 100.79M
Other Long-Term Assets
13.38M 35.72M -186.46M 30.65M
Receivables
709.11M 358.03M 198.98M 500.18M
Inventory
494.99M 416.12M 282.35M 242.63M
Other Current Assets
25.19M 166.61M 133.66M 128.71M
Total Current Assets
3.99B 4.2B 4.71B 7.61B
Property-Plant & Equipment
1.66B 1.42B 845.95M 686.74M
Goodwill & Intangibles
129.76M 57.14M 94.68M 103.46M
Total Long-Term Assets
1.93B 1.6B 845.95M 1.03B
Total Assets
5.92B 5.81B 6.38B 8.65B
Account Payables
405M 315.11M 294.78M 168.04M
Deferred Revenue
n/a n/a 255.89M 407.7M
Short-Term Debt
851.53M 688.37M 328.97M 427.56M
Other Current Liabilities
359.5M 195.97M -109.87M 353.34M
Total Current Liabilities
2.21B 1.81B 1.02B 1.6B
Long-Term Debt
166.48M 197.62M 209.15M 202.11M
Other Long-Term Liabilities
90.7M 237.97M 734.25M 558.25M
Total Long-Term Liabilities
373.79M 457.83M 977.91M 803.41M
Total Liabilities
2.59B 2.27B 2B 2.4B
Total Debt
1.08B 930.18M 891.13M 694.64M
Common Stock
138K 135K 135K 133K
Retained Earnings
-8.61B -7.96B -7.08B -4.97B
Comprehensive Income
-148.99M -99.45M -77.42M 17.95M
Shareholders Equity
3.33B 3.54B 4.38B 6.24B
Total Investments
128.93M 92.24M 757.03M 2.34B